| Peer-Reviewed

Cardiorenal Syndrome in Acute Coronary Disease: A Current Perspective

Received: 26 June 2019    Accepted: 4 August 2019    Published: 3 September 2019
Views:       Downloads:
Abstract

Acute coronary disease is one of the leading causes of death in the world. Currently 20-30% of these patients have acute renal failure forming part of the cardiorenal syndrome. Studies show that the evaluation of renal function through the estimated glomerular filtration rate (eGFR) is related to mortality in patients with cardiovascular disease, with greater precision in eGFR Chronic Kidney Disease Epidemiology Collaboration. Therefore, it is considered an immediate, easy and useful marker for the initial evaluation of patients with acute coronary disease.

Published in Cardiology and Cardiovascular Research (Volume 3, Issue 3)
DOI 10.11648/j.ccr.20190303.12
Page(s) 52-54
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Acute Coronary Syndrome, Glomerular Filtration, Acute Renal Failure

References
[1] Parra Fuertes PJ, de la Fuente SI. Síndrome coronario agudo sin elevación persistente del segmento ST. En: Montejo CJ, de Lorenzo GA, Marco P, Ortiz C. Manual de medicina intensiva. 5ta edición. España: Elsevier; 2017. p. 105-109.
[2] Gutiérrez HB, Benítez FDM (2018) Valor pronóstico de la función renal a corto plazo en pacientes con infarto agudo de miocardio. Revista Colombiana de Cardiología 25: 26-32.
[3] Rodríguez-Jiménez AE, Negrín-Valdés T, Cruz-Inerarity H, Machural-de la Torre PJ. Síndrome cardiorrenal como predictor de mortalidad intrahospitalaria en el síndrome coronario agudo con elevación del segmento ST. Clínica e Investigación en Arteriosclerosis. 2018; 30 (4): 163-9.
[4] Górriz Teruel JL, Beltrán Catalán S. Valoración de afección renal, disfunción renal aguda e hiperpotasemia por fármacos usados en cardiología y nefrotoxicidad por contrastes. Rev Esp Cardiol. 2011; 64: 1182-92.
[5] Grodin JL. Hemodynamically, the kidney is at the heart of cardiorenal syndrome. CLEVELAND CLINIC 9500 EUCLID AVE, CLEVELAND, OH 44106 USA; 2018.
[6] Di Lullo L, Bellasi A, Russo D, Cozzolino M, Ronco C. Cardio-renal acute kidney injury: Epidemiology, presentation, causes, pathophysiology and treatment. Int J Cardiol. 2017; 227: 143-50. 5.
[7] Hanada S, Takewa Y, Mizuno T, Tsukiyan T, Taenaka Y, Tatsumi E, et al. Effect of the technique for assisting renal blood circula-tion on ischemic kidney in acute cardiorenal syndrome. J ArtifOrgans. 2012; 15: 140-5.
[8] Lobo Márquez LL, de la Serna F. Síndrome cardiorrenal. Rev Fed Arg Cardiol. 2013; 42: 88-95.
[9] Flores Blanco JP. Papel Pronóstico de Nuevos Métodos de Valoración de la Función Renal en Insuficiencia Cardiaca Aguda y Síndrome Coronario Agudo sin elevación del Segmento ST [Tesis Doctoral]. España: Universidad de Murcia; 2016.
[10] Mora SD, Dávila EZ, Silva EN, Mesquita ET, Martins WdA, Villacorta Junior H. Síndrome cardio-renal tipo 1: Mecanismos fisiopatológicos y papel de los nuevos biomarcadores. Insuficiencia cardíaca. 2016; 11 (1): 55-62.
[11] Tan K, Sethi S. Biomarkers in cardiorenal syndromes. TranslRes 2014; 164 (2): 122-34.
[12] Seller Pérez G, Herrera Gutiérrez ME, Arias Verdú MD, De la Torre Prados MV, Cota Delgado. Fisiopatología de la insuficiencia renal aguda. Lesión renal en el paciente crítico. En: Cárdenas Cruz A, Roca Guiseris J, editores. Tratado de Medicina Intensiva. Barcelona: Elsevier; 2017. p. 395-9.
[13] Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, White HD, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004; 351: 1285-1295.
[14] Jose P, Skali H, Anavekar N, Tomson C, Krumholz HM, Rouleau JL, et al. Increase in creatinine and cardiovascular risk in patients with systolic dysfunction after myocardial infarction. J Am Soc Nephrol 2006; 17: 2886-2891.
[15] Landry DW, Bazari H. Aproximación al paciente con enfermedad renal. En: Goldman-Cecil. Tratado de medicina interna + Expert Consult. 25a Edición. Elsevier: España, 2017; 114: 728-36.
[16] Eagle KA, Lim MJ, Dabbous OH, Pieper KS, Goldberg RJ van de Werf F, et al. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. GRACE Investigators. JAMA. 2004; 291: 2727-33.
[17] Halkin A, Singh M, Nikolsky E, et al. Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score. J Am Coll Cardiol 2005; 45 (9): 1397-405.
[18] Sánchez A, Pou M, Leiro R, López Gómez D, Martínez Ruiz M. D, Saurina A, et al. El grado de insuficiencia renal como predictor de mortalidad tras un síndrome coronario agudo. Nefrología 2009; 29 (1): 53-60.
Cite This Article
  • APA Style

    Hedgar Berty Gutiérrez, Yenisey Arteaga Concepción, Cristians Auza-Santivañez. (2019). Cardiorenal Syndrome in Acute Coronary Disease: A Current Perspective. Cardiology and Cardiovascular Research, 3(3), 52-54. https://doi.org/10.11648/j.ccr.20190303.12

    Copy | Download

    ACS Style

    Hedgar Berty Gutiérrez; Yenisey Arteaga Concepción; Cristians Auza-Santivañez. Cardiorenal Syndrome in Acute Coronary Disease: A Current Perspective. Cardiol. Cardiovasc. Res. 2019, 3(3), 52-54. doi: 10.11648/j.ccr.20190303.12

    Copy | Download

    AMA Style

    Hedgar Berty Gutiérrez, Yenisey Arteaga Concepción, Cristians Auza-Santivañez. Cardiorenal Syndrome in Acute Coronary Disease: A Current Perspective. Cardiol Cardiovasc Res. 2019;3(3):52-54. doi: 10.11648/j.ccr.20190303.12

    Copy | Download

  • @article{10.11648/j.ccr.20190303.12,
      author = {Hedgar Berty Gutiérrez and Yenisey Arteaga Concepción and Cristians Auza-Santivañez},
      title = {Cardiorenal Syndrome in Acute Coronary Disease: A Current Perspective},
      journal = {Cardiology and Cardiovascular Research},
      volume = {3},
      number = {3},
      pages = {52-54},
      doi = {10.11648/j.ccr.20190303.12},
      url = {https://doi.org/10.11648/j.ccr.20190303.12},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ccr.20190303.12},
      abstract = {Acute coronary disease is one of the leading causes of death in the world. Currently 20-30% of these patients have acute renal failure forming part of the cardiorenal syndrome. Studies show that the evaluation of renal function through the estimated glomerular filtration rate (eGFR) is related to mortality in patients with cardiovascular disease, with greater precision in eGFR Chronic Kidney Disease Epidemiology Collaboration. Therefore, it is considered an immediate, easy and useful marker for the initial evaluation of patients with acute coronary disease.},
     year = {2019}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Cardiorenal Syndrome in Acute Coronary Disease: A Current Perspective
    AU  - Hedgar Berty Gutiérrez
    AU  - Yenisey Arteaga Concepción
    AU  - Cristians Auza-Santivañez
    Y1  - 2019/09/03
    PY  - 2019
    N1  - https://doi.org/10.11648/j.ccr.20190303.12
    DO  - 10.11648/j.ccr.20190303.12
    T2  - Cardiology and Cardiovascular Research
    JF  - Cardiology and Cardiovascular Research
    JO  - Cardiology and Cardiovascular Research
    SP  - 52
    EP  - 54
    PB  - Science Publishing Group
    SN  - 2578-8914
    UR  - https://doi.org/10.11648/j.ccr.20190303.12
    AB  - Acute coronary disease is one of the leading causes of death in the world. Currently 20-30% of these patients have acute renal failure forming part of the cardiorenal syndrome. Studies show that the evaluation of renal function through the estimated glomerular filtration rate (eGFR) is related to mortality in patients with cardiovascular disease, with greater precision in eGFR Chronic Kidney Disease Epidemiology Collaboration. Therefore, it is considered an immediate, easy and useful marker for the initial evaluation of patients with acute coronary disease.
    VL  - 3
    IS  - 3
    ER  - 

    Copy | Download

Author Information
  • Intensive Care Department, University Clinical-Surgical Hospital “Miguel Enríquez”, Havana, Cuba

  • Intensive Care Department, University Clinical-Surgical Hospital “Miguel Enríquez”, Havana, Cuba

  • Sections